Filters

Thymic factor Polylconal Antibody

Thymic factor Polylconal Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameThymic factor Polylconal Antibody
Also known asThymic factor Polylconal Antibody
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenThymic factor
SpecificityThis is a highly specific antibody against Thymic factor
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceKLH conjugated synthetic peptide derived from pig Thymic factor
Tested Applications IF(IHC-P), IHC-P
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500)
Cross reactivityHuman
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen a nonapeptide secreted by the thymus, is an essential hormone for T lymphocyte differentiation and function, Thymulin
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names THYF_PIG, Thymic factor
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Description Complex subunit associated factors are involved in hybridoma growth, Eosinohils, NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation, Aplha
Gene targetThymic factor Polylconal
Short nameThymic factor Polylconal Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameThymic factor Polylconal (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter